Your browser doesn't support javascript.
loading
A de novo ANK1 mutation in a childhood hereditary spherocytosis: a case report.
Wang, Yafeng; Liu, Linlin; Liu, Dandan; Liu, Wei.
  • Wang Y; Department of Hematology and Oncology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, No.33 Longhuwaihuan East Road, Zhengzhou, 450018, China. xywangyafeng@126.com.
  • Liu L; Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. xywangyafeng@126.com.
  • Liu D; Department of Hematology and Oncology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, No.33 Longhuwaihuan East Road, Zhengzhou, 450018, China.
  • Liu W; Department of Electrocardiogram, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, 450018, China.
BMC Pediatr ; 23(1): 267, 2023 05 29.
Article en En | MEDLINE | ID: mdl-37246216
ABSTRACT

BACKGROUND:

Due to the heterogeneity of the phenotype of Hereditary spherocytosis (HS) patients, some patients may have rare clinical complications such as biliary obstruction and ultra-high bilirubinemia. CASE PRESENTATION A 8-y-old boy presented to the emergency with complaints of anemia for 6 years and worsened abdominal pain and scleral yellowing of the skin for 2 days. Physical examination showed tenderness in the middle and upper abdomen and splenomegaly. Abdominal CT revealed biliary obstruction. Genetic analysis revealed a de novo mutation in the gene ANK1, HS with biliary obstruction was diagnosed. The surgery of bile duct exploration and T-tube drainage, and splenectomy were performed successively. This patient was followed up for 13 months after splenectomy, and his condition was stable.

CONCLUSION:

The diagnosis of HS is not clinically difficult, and once a patient with HS is diagnosed, regular follow-up management and standardized treatment are required. Genetic testing is also needed to screen for other genetic disorders that may co-exist in patients with HS who do not have a good efficacy or who have a long-term chronic onset of jaundice.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esferocitosis Hereditaria / Colestasis Tipo de estudio: Diagnostic_studies Límite: Child / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esferocitosis Hereditaria / Colestasis Tipo de estudio: Diagnostic_studies Límite: Child / Humans Idioma: En Año: 2023 Tipo del documento: Article